Skip to main content

ADHD is a common neurobiological disorder whose symptoms include difficulty paying attention, trouble controlling behaviour and impulsiveness.

iStockphoto/iStockphoto

Mental-health advocacy organizations in British Columbia are calling out the province for falling behind the rest of the country when it comes to treating attention deficit hyperactivity disorder.

The Canadian ADHD Resource Alliance and Canada's Centre for ADHD Awareness say the province is failing to offer a full range of treatments for the mental disorder.

They say the shortcoming has social and financial impacts for both Canadians and the medical system.

Story continues below advertisement

The groups demand the province widen its coverage of long-acting ADHD medications, which they say are more effective and have fewer side effects than other treatments.

They say B.C. is one of the only provinces to not finance a variety of long-acting medications under PharmaCare.

ADHD is a common neurobiological disorder whose symptoms include difficulty paying attention, trouble controlling behaviour and impulsiveness.

Report an error
Comments

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • All comments will be reviewed by one or more moderators before being posted to the site. This should only take a few moments.
  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed. Commenters who repeatedly violate community guidelines may be suspended, causing them to temporarily lose their ability to engage with comments.

Read our community guidelines here

Discussion loading ...

Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.
Cannabis pro newsletter